Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59
Clinical trial NCT03497845 · COMPLETED
Trial details
- NCT number
- NCT03497845
- Sponsor
- Biomedical Advanced Research and Development Authority
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2019-11-19
- Enrollment
- 720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.